What Is GLP-1?

How a hormone released after meals helps regulate blood sugar and appetite, and what happens when a medication extends that signal.

When someone says they’re “taking a GLP-1,” they usually mean they’re taking a prescription medication such as semaglutide or tirzepatide. But GLP-1 itself is a hormone your body makes. Your gut releases it when you eat, and it helps coordinate what happens next. It tells the pancreas to release more insulin when blood sugar is elevated, affects how quickly food leaves the stomach, and plays a role in how full you feel. American Physiological Society

The natural hormone is broken down within minutes. Prescription drugs can activate the same receptor for much longer. That difference helps explain why a meal can trigger GLP-1 release while a GLP-1 medication can influence appetite and blood sugar well beyond that meal. It also explains why a food or supplement advertised as a “GLP-1 booster” is a different proposition from a prescription drug tested for a specific medical use. American Physiological Society

What does GLP-1 stand for?

GLP-1 stands for glucagon-like peptide-1. A peptide is a short chain of amino acids. Despite the similar names, GLP-1 and glucagon have different jobs. Glucagon signals the liver to release glucose when your body needs it. GLP-1 helps coordinate the response to incoming nutrients, including dialing back glucagon when blood sugar is elevated. American Physiological Society

GLP-1 is one of the gut hormones known as incretins. The other major incretin is GIP, short for glucose-dependent insulinotropic polypeptide. Both help the pancreas respond to nutrients after eating. Specialized cells in the intestine called L cells release GLP-1 as they sense nutrients. Carbohydrates, fats, and components of protein can all contribute to that signal. pubmed.ncbi.nlm.nih.gov

What does GLP-1 do after you eat?

Imagine you’ve just had lunch. As you digest it, nutrients arrive in the intestine and glucose starts entering your bloodstream. GLP-1 helps your pancreas, digestive system, and brain respond to that meal.

It helps the pancreas release insulin when glucose rises

Insulin helps move glucose out of the bloodstream and into cells. GLP-1 strengthens the pancreas’s insulin response when glucose is elevated. This is called a glucose-dependent effect because the strength of the response depends in part on how much glucose is circulating. For someone with type 2 diabetes, a medication that acts on this pathway can help lower blood sugar. American Physiological Society

Glucose dependence also helps explain why low blood sugar is generally less likely with a GLP-1 receptor agonist used alone than when it’s combined with insulin or a medicine such as a sulfonylurea. If you take either, your prescriber may need to adjust your treatment or ask you to check your glucose more often. accessdata.fda.gov

It helps regulate how much glucose the liver releases

Your liver helps keep glucose available between meals. After eating, when glucose is arriving from the food you’ve digested, GLP-1 helps reduce glucagon release. With less glucagon signaling, the liver releases less glucose. Think of the pancreas and liver as handling two parts of the same job: dealing with glucose already in the bloodstream and regulating how much more enters it. American Physiological Society

It can slow stomach emptying

Stomach emptying is the movement of food from the stomach into the small intestine. GLP-1 can slow that movement, which affects how quickly nutrients become available for absorption. This action matters when taking certain GLP-1 medications. It can affect how some oral medicines are absorbed, and it’s one reason to tell your procedure team if you take a GLP-1 drug and are scheduled for anesthesia or deep sedation. American Physiological Society

It plays a role in appetite and fullness

GLP-1 also acts on pathways involved in appetite. With a prescription medication, some people notice they feel satisfied sooner during a meal or are less hungry between meals. Those changes can make it easier to eat less over time. How much appetite changes varies by person, and changes in appetite and digestive side effects are both worth discussing at follow-up. American Physiological Society

How are GLP-1 medications different from the hormone?

An enzyme called DPP-4 breaks down active natural GLP-1 quickly. The intact hormone has a half-life of about two minutes. Your intestine can keep releasing it while you absorb nutrients, so the overall response to a meal lasts longer than any one molecule. Prescription GLP-1 receptor agonists are designed to keep acting for longer. Some are taken daily, while others, such as injectable semaglutide, are taken weekly. American Physiological Society

The term receptor agonist means a drug activates a receptor. A GLP-1 receptor agonist activates the receptor that responds to natural GLP-1. Tirzepatide is often grouped with GLP-1 medications in everyday conversation, but it activates both the GIP and GLP-1 receptors. That’s what people mean when they call it a dual agonist. pubmed.ncbi.nlm.nih.gov

The ingredient, brand, and formulation each tell you something different. Semaglutide is an active ingredient. Wegovy and Ozempic are brand names with their own approved uses and instructions. Even within a brand, the formulation matters. Wegovy, for example, has injectable and oral forms in the United States. Ask your prescriber or pharmacist before switching products, forms, or doses. www.niddk.nih.gov

These examples show why it helps to ask for the exact product name. Some products have additional approved uses, and eligibility and instructions depend on the product and formulation. www.niddk.nih.gov

Why might a clinician prescribe a GLP-1 medication?

To help manage type 2 diabetes

Certain GLP-1 medications help lower blood sugar and improve A1C, which reflects average blood glucose over roughly three months. A clinician considers your blood sugar goals, other medications, health history, and ability to tolerate the treatment. Some products also have FDA-approved uses related to cardiovascular or kidney risk in specific groups. The details depend on the product and the population covered by its label. www.niddk.nih.gov

To support long-term weight management

Certain products are approved for chronic weight management alongside changes in eating and physical activity. Common U.S. prescribing criteria for adults include a body mass index of 30 or higher, or 27 or higher with a weight-related condition, such as high blood pressure or type 2 diabetes. Those criteria can help start a conversation. The decision also depends on medical history, expected benefit, side effects, and whether the treatment is something you can continue. www.niddk.nih.gov

A practical question before starting is how you and your clinician will know the treatment is helping. If blood sugar is the main reason, you might discuss A1C or home glucose readings. If weight management is the main reason, you might discuss weight trends alongside appetite, side effects, and how treatment fits your daily life. Ask when you’ll review progress and what would make you reconsider the plan. www.niddk.nih.gov

What does starting treatment look like?

Many GLP-1 medications start at a lower dose and increase in steps. The schedule is specific to the product and gives your body time to adjust. If nausea or other symptoms are still affecting your meals when you’re due for an increase, ask your prescriber what to do. Missed-dose instructions also vary, so check the directions for your specific medicine. www.accessdata.fda.gov

It helps to know what you’ll do if the routine changes. If you travel often, ask your pharmacist how to store and transport the medication. If you take several medicines in the morning, ask whether the timing matters for your particular GLP-1 product. If you use insulin, ask whether you need a plan for checking glucose more often, especially if your appetite changes and you start eating less. www.accessdata.fda.gov

At a follow-up visit, specifics are useful. “I’ve felt nauseated twice since the last dose increase, and once I couldn’t finish lunch” gives your clinician more to work with than “my stomach feels off.” Let them know if symptoms affect your ability to drink fluids or eat regularly. Bring a list of your medications and supplements, including anything you started after your last visit. www.niddk.nih.gov

What side effects and warnings should you know about?

Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal discomfort. They can be more noticeable as the dose increases. Contact your prescriber if symptoms persist, worsen, or interfere with eating and drinking. Ongoing vomiting or diarrhea can lead to dehydration, which can also affect kidney function. www.accessdata.fda.gov

Get urgent medical advice for severe abdominal pain that doesn’t go away, especially if it spreads to your back, or if repeated vomiting makes it impossible to keep fluids down. Some products carry warnings about pancreatitis and gallbladder problems. Seek emergency care for trouble breathing or swelling of the face, lips, tongue, or throat, which can be signs of a serious allergic reaction. www.accessdata.fda.gov

A few details are especially important to bring up before starting:

• Thyroid cancer history. Wegovy and Zepbound carry boxed warnings about thyroid tumors seen in rodents. Whether they cause these tumors in humans is unknown. Their labels say people with a personal or family history of medullary thyroid carcinoma or with multiple endocrine neoplasia type 2, also called MEN2, should not take them. www.accessdata.fda.gov
• Digestive problems or an upcoming procedure. Tell your prescriber if you have severe gastroparesis, a condition in which the stomach empties slowly. Tell your procedure team if you take one of these medications and are scheduled for anesthesia or deep sedation. Follow that team’s instructions about managing the medication before the procedure. accessdata.fda.gov
• Pregnancy plans. If you’re pregnant, planning a pregnancy, or become pregnant during treatment, contact your prescriber. Weight-loss use and pregnancy timing have product-specific instructions. For example, the Wegovy label advises stopping semaglutide at least two months before a planned pregnancy when it’s used for weight reduction. www.niddk.nih.gov

What happens when you stop a GLP-1 medication?

The effects can change as the medicine wears off. Appetite may return, weight may increase, and blood sugar can change if the medication was helping manage it. In a follow-up to the STEP 1 trial, participants who had taken semaglutide regained, on average, about two-thirds of the weight they had lost one year after the medication and the trial’s structured lifestyle support ended. That result describes a particular group and treatment plan. Individual experiences vary. pubmed.ncbi.nlm.nih.gov

If you’re considering stopping because of cost, side effects, or availability, ask what follow-up should look like. For someone taking the drug for diabetes, that may mean deciding when to check blood sugar and whether another treatment is needed. For someone taking it for weight management, the discussion may include what to do if hunger returns or weight starts trending up. Having a plan in place before the last dose gives you a clearer idea of when to check in. www.niddk.nih.gov

Can food or supplements increase GLP-1?

Eating naturally stimulates GLP-1 release. Carbohydrates, fats, and amino acids from protein can all contribute. The body breaks the active hormone down quickly, and the amount released varies with what’s being digested. That temporary response is part of how your body handles a meal. American Physiological Society

If a supplement claims to “boost GLP-1,” look at what was actually measured. A study showing a temporary rise in a hormone after a single meal answers a narrow question. Evidence about long-term weight change, A1C, or side effects requires studies that measure those outcomes. Check whether the research used the same ingredient, formulation, and dose as the product being sold. American Physiological Society

How do compounded GLP-1 drugs fit in?

A compounded GLP-1 drug is a medication prepared by a pharmacy or outsourcing facility. In the U.S., the FDA does not review compounded drugs for safety, effectiveness, and quality before they’re marketed. The agency has reported dosing errors involving compounded injections and warns about products sold as “research use only” directly to consumers. If a clinician recommends a compounded product, ask why an approved drug can’t meet your needs, which pharmacy will fill it, and exactly how to measure the dose. FDA

Common questions about GLP-1

Is GLP-1 insulin?

GLP-1 helps the pancreas release insulin when glucose is elevated. Insulin itself is the hormone that helps move glucose into cells. If you use prescribed insulin, ask your care team how any new treatment fits into your regimen before changing a dose. pubmed.ncbi.nlm.nih.gov

Are all GLP-1 medicines injections?

Some are available as tablets. The oral and injectable forms can have different directions, even when they share an active ingredient. If you’re comparing options, ask your clinician or pharmacist how you’d take each one and whether it fits your routine. www.niddk.nih.gov

Is tirzepatide the same as semaglutide?

They’re different active ingredients. Semaglutide activates the GLP-1 receptor, while tirzepatide activates both GIP and GLP-1 receptors. Both can affect appetite and blood sugar, and each has its own dosing instructions, approved uses, and warnings. www.accessdata.fda.gov

Does feeling less hungry mean the treatment is working?

Reduced hunger can be one effect, but what counts as progress depends on why the medication was prescribed. If the goal is to manage type 2 diabetes, blood glucose and A1C can provide information that appetite alone can’t. If the goal is weight management, review the weight trend and whether side effects are interfering with daily life. www.niddk.nih.gov

Questions to bring to your next appointment

If you’re considering treatment, bring the name of the product you’re asking about and a list of the medicines and supplements you take. These questions can help you leave with a clearer plan:

1. What would this medication help me manage? Ask what you’ll track and when you’ll review it.
2. How do I take this specific product? Ask about timing, missed doses, and dose increases.
3. Does it change how I use any other medication? Ask especially about insulin or other medicines that can cause low blood sugar.
4. Which symptoms should prompt a call or urgent care? Write down what to do if you can’t keep fluids down or develop severe pain.
5. What’s the plan if I need to stop or switch? Ask how you’ll follow up if appetite, weight, or blood sugar changes.